This site tells you about cancer immunotherapy.
It is designed for people with lung cancer or melanoma and their families who may be interested in finding out about this potential new treatment that is being studied in clinical trials.
Cancer immunotherapy is a potential new type of cancer treatment that teaches your own immune system to fight and destroy cancer cells. One type of cancer immunotherapy is called ASCI*. ASCI* is being developed by GlaxoSmithKline (GSK) as a potential new treatment for certain types of lung cancer. It is currently being tested in two large clinical trial involving thousands of lung cancer patients. The trial in lung cancer is called the MAGRIT study, and the trial in melanoma is called the DERMA study. Clinical trials are carefully controlled studies carried out to see whether new treatments are effective and safe.
Use the menu at the bottom of the page to take you to the section of the site you are interested in. You can learn more about cancer and how it is treated. Or you can find out more about cancer immunotherapy and ASCI*. To learn more about lung cancer, including the types and stages of lung cancer, go to Lung cancer and ASCI. This section also tells you how ASCI could potentially be used to treat lung cancer.
If you have lung cancer you may be interested in taking part in the MAGRIT study.
To learn more about melanoma and its potential treatment with ASCI, go to Melanoma and ASCI. If you have melanoma you may want to find out about taking part in the DERMA study
Information about cancer
What you should know about cancer
Cancer Immunotherapy
How therapy can teach your own immune system to fight cancer
ASCI* Treatment
A new approach to cancer immunotherapy
ASCI* in the treatment of Lung Cancer
ASCI* in development for the treatment of a specific class of lung cancer
Melanoma treatment and ASCI*
ASCI* is a potential new melanoma treatment
MAGRIT: a large-scale clinical study in Non Small Cell Lung Cancer
Learn how the MAGRIT study intends to validate the value of ASCI* in the treatment of Non Small Cell Lung Cancer.
What is ASCI*?
ASCI* or Antigen Specific Immunotherapeutics is an new immunotherapy that is designed to teach your own immune system to fight targeted cancer cells. One ASCI* is made-to-target lung cancer cells.
